Back to news

Why Abbott Laboratories (ABT) Stock Is Down Today

Investivoq PriceTracker

Abbott Laboratories (ABT) is down 4.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The sell-off appears tied to Abbott’s third-quarter update, which paired an in-line profit result with a cut to its full-year comparable sales growth outlook and a surprise plan to separate its Nutrition business. Investors may also be reassessing the value and risk profile of the remaining company and the future standalone nutrition unit.

Details:

  • Abbott reported third-quarter 2026 adjusted diluted EPS of $1.42, while sales rose 14.5% on a reported basis and 7.0% on a comparable basis. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1800/000162828026066601/abt-2026q3xexhibitx991.htm?utm_source=openai))
  • Abbott lowered full-year 2026 comparable sales growth guidance to about 6.0%, versus its prior 6.5% to 7.5% outlook given in July. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1800/000162828026066601/abt-2026q3xexhibitx991.htm?utm_source=openai))
  • The company also announced a plan to separate its Nutrition business into an independent public company through a tax-free distribution to shareholders, with completion targeted by the end of 2027. ([abbottinvestor.com](https://www.abbottinvestor.com/static-files/0c63c400-601e-47d1-8ece-a9595e65ff85))
  • Management’s separation materials describe Nutrition as an approximately $8.5 billion sales business, while the remaining Abbott would become more concentrated in medical devices, diagnostics, and established pharmaceuticals. ([abbottinvestor.com](https://www.abbottinvestor.com/static-files/0c63c400-601e-47d1-8ece-a9595e65ff85))

    • Sources:

    SEC, Abbott Investor Relations, Yahoo Finance ([sec.gov](https://www.sec.gov/Archives/edgar/data/1800/000162828026066601/abt-2026q3xexhibitx991.htm?utm_source=openai))

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $ABT Insider Trading Activity

    ABT Insider Trades

    $ABT insiders have traded $ABT stock on the open market 7 times in the past 6 months. Of those trades, 3 have been purchases and 4 have been sales.

    Here’s a breakdown of recent trading of $ABT stock by insiders over the last 6 months:

    • ROBERT B FORD (CHAIRMAN AND CEO) has made 0 purchases and 2 sales selling 398,832 shares for an estimated $46,204,798.
    • DANIEL J STARKS purchased 10,000 shares for an estimated $926,537
    • LOUIS H. MORRONE (EXECUTIVE VICE PRESIDENT) sold 5,850 shares for an estimated $642,505
    • PHILIP P BOUDREAU (EVP AND CFO) purchased 2,200 shares for an estimated $201,300
    • JOHN G STRATTON purchased 2,000 shares for an estimated $173,640
    • JOHN A. JR. MCCOY (VICE PRESIDENT AND CONTROLLER) sold 27 shares for an estimated $2,957

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    Investivoq Alerts
    Receive ABT Data Alerts
    Get market-moving data, filings, and signals for ABT in real time.
    Sign Up

    $ABT Hedge Fund Activity

    We have seen 1,243 institutional investors add shares of $ABT stock to their portfolio, and 1,622 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 59,674,507 shares (+inf%) to their portfolio in Q2 2026, for an estimated $5,414,864,765
    • WELLINGTON MANAGEMENT GROUP LLP removed 18,765,809 shares (-69.3%) from their portfolio in Q2 2026, for an estimated $1,702,809,508
    • JPMORGAN CHASE & CO added 15,095,898 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,369,801,784
    • CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 14,174,452 shares (+31.2%) to their portfolio in Q2 2026, for an estimated $1,286,189,774
    • CAPITAL RESEARCH GLOBAL INVESTORS removed 12,866,372 shares (-25.8%) from their portfolio in Q2 2026, for an estimated $1,167,494,595
    • T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 12,502,246 shares (-97.9%) from their portfolio in Q2 2026, for an estimated $1,134,453,802
    • BLACKROCK, INC. added 6,876,018 shares (+4.7%) to their portfolio in Q2 2026, for an estimated $623,929,873

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $ABT Government Contracts

    We have seen $136,887,260 of award payments to $ABT over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    • CIVILIAN DRUG FREE WORKPLACE COLLECTIONS AND MEDICAL REVIEW SUPPORT SERVICES.: $6,560,835
    • LAB CHEMISTRY SERVICES: $2,894,074

    To track government contracts to publicy traded companies, check out Investivoq's government contracts dashboard. You can access data on government contracts through the Investivoq API government contracts endpoint.

    $ABT Congressional Stock Trading

    Members of Congress have traded $ABT stock 11 times in the past 6 months. Of those trades, 4 have been purchases and 7 have been sales.

    Here’s a breakdown of recent trading of $ABT stock by members of Congress over the last 6 months:

    • REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 09/18, 06/16 and 1 sale worth up to $15,000 on 05/15.
    • REPRESENTATIVE RICHARD MCCORMICK has traded it 3 times. They made 2 purchases worth up to $30,000 on 06/12 and 1 sale worth up to $15,000 on 07/30.
    • REPRESENTATIVE MIKE KELLY sold up to $15,000 on 07/17.
    • REPRESENTATIVE RICK W. ALLEN sold up to $50,000 on 07/14.
    • REPRESENTATIVE RICK LARSEN sold up to $15,000 on 07/08.
    • REPRESENTATIVE JOSH GOTTHEIMER sold up to $15,000 on 05/27.
    • REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 05/12.

    To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.

    $ABT Price Targets

    Multiple analysts have issued price targets for $ABT recently. We have seen 4 analysts offer price targets for $ABT in the last 6 months, with a median target of $118.0.

    Here are some recent targets:

    • Vijay Kumar from Evercore ISI Group set a target price of $112.0 on 07/06/2026
    • David Rescott from Baird set a target price of $121.0 on 07/01/2026
    • Adam Maeder from Piper Sandler set a target price of $115.0 on 06/22/2026
    • Marie Thibault from BTIG set a target price of $131.0 on 04/27/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.